Ann Tomlin
Ufficiale delle Risorse Umane presso LYELL IMMUNOPHARMA, INC.
Profilo
Ann Tomlin is currently working as the Senior Vice President-Human Resources at Lyell Immunopharma, Inc. She previously worked as the Head-Human Resources at AbbVie, Inc. and as the Senior Vice President-Human Resources at Myovant Sciences Ltd.
Ms. Tomlin holds a graduate degree from Loyola University of Chicago and an undergraduate degree from the University of Illinois At Urbana–Champaign.
Posizioni attive di Ann Tomlin
| Società | Posizione | Inizio |
|---|---|---|
| LYELL IMMUNOPHARMA, INC. | Ufficiale delle Risorse Umane | 01/07/2023 |
Precedenti posizioni note di Ann Tomlin
| Società | Posizione | Fine |
|---|---|---|
| MYOVANT SCIENCES LTD. | Ufficiale delle Risorse Umane | 01/06/2023 |
| ABBVIE INC. | Ufficiale delle Risorse Umane | - |
Formazione di Ann Tomlin
| Loyola University of Chicago | Graduate Degree |
| University of Illinois At Urbana–Champaign | Undergraduate Degree |
Esperienze
Posizioni ricoperte
Relazioni
Relazioni di 1° grado
Aziende connesse in 1º grado
Uomo
Donna
Amministratori
Dirigenti
Società collegate
| Società quotate in Borsa | 2 |
|---|---|
| ABBVIE INC. | Health Technology |
| LYELL IMMUNOPHARMA, INC. | Health Technology |
| Aziende private | 1 |
|---|---|
Myovant Sciences Ltd.
 Myovant Sciences Ltd. BiotechnologyHealth Technology Myovant Sciences Ltd. is a clinical-stage biopharmaceutical company, which engages in the development and commercialization of therapies for the treatment of women's health and endocrine diseases. It offers ORGOVYXTM, an oral gonadotropin-releasing hormone (GnRH) receptor antagonist for the treatment of adult patients with advanced prostate cancer, and MYFEMBREE, which is taken for the management of heavy menstrual bleeding associated with uterine fibroids. The company was founded on February 2, 2016 and is headquartered in London, the United Kingdom. | Health Technology |
- Borsa valori
- Insiders
- Ann Tomlin
